Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2011 ... - MarketWatch (press release) PDF Print
MarketWatch (press release)
Keryx Biopharmaceuticals is focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of cancer and renal disease. Keryx is developing KRX-0401 (perifosine), a novel, ...
Keryx Biopharmaceuticals, Inc. to Host Conference Call on Fourth Quarter and

...

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.